Skip to main content
. 2018 Sep 11;9:2054. doi: 10.3389/fimmu.2018.02054

Table 1.

Immunophenotypic characterization of BM-derived T-cells.

Blood (N = 18) BM (N = 20) LN (N = 18)
Lymphocytes 59.0 (17.6) 23.6 (6.7) 69.9 (12.7)
CD4+ 18.2 (7.0) 1.4 (1.9) 31.9 (12.2)
CD8+ 24.4 (8.1) 6.7 (6.3) 16.4 (4.6)
CD4/CD8 ratio 0.9 (0.6) 0.2 (0.1) 2.1 (1.0)
CD4+ CD8+ CD4+ CD8+ CD4+ CD8+
CCR7 (memory) 40.0 (17.5) 80.2 (13.3) 88.3 (5.7) 97.8 (1.3) 30.2 (7.7) 46.0 (16.1)
CD62L 45.5 (17.1) 64.6 (14.8) 92.7 (4.3) 94.0 (2.6) 41.6 (14.8) 43.0 (13.7)
CCR7CD62L (DN-M) 26.5 (9.0) 59.8 (13.1) 83.4 (6.7) 92.3 (2.6) 20.7 (6.9) 32.6 (14.0)

Flow cytometric analysis was used to assess the percentage of blood, LN and BM-derived mononuclear cells expressing CD4, CD8, CCR7, and CD62L. Percentage lymphocytes based on FSC/SSC within the total events, percentage of CD4+ and CD8+ cells within total lymphocytes, CD4/CD8 ratios, and percentage of CCR7 (memory), CD62L and CCR7CD62L (DN-M) cells within the total CD4+ and CD8+ lymphocyte populations are shown. N = number of animals analyzed. We report mean and standard deviation (SD).